RDGL 8-K 2026-11-05

VIVOS INC (RDGL) 8-K dated 2026-11-05 — accession 0001493152-26-050077.

VIVOS INC (RDGL) is a medical devices company listed on US.

VIVOS INC filed a 8-K on 2026-11-05. Accession 0001493152-26-050077.

This 8-K covers: Unregistered share sale (Item 3.02), Shareholder nominations (Item 5.08), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported RDGL revenue for 2025-12-31 was $68.4K. Net income was -$3.1M. Revenue was up 250.7% from 2023-12-31 to 2025-12-31. RDGL currently screens at market cap $54.0M.

Not investment advice. The RDGL SEC hub lists recent forms. The stock page is the research view.